169,132 OrthoPediatrics Corp. $KIDS Shares Purchased by Riverbridge Partners LLC

Riverbridge Partners LLC lifted its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 108.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 324,447 shares of the company’s stock after buying an additional 169,132 shares during the period. Riverbridge Partners LLC owned approximately 1.24% of OrthoPediatrics worth $7,225,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of KIDS. AIGH Capital Management LLC lifted its stake in OrthoPediatrics by 334.4% during the 3rd quarter. AIGH Capital Management LLC now owns 1,171,765 shares of the company’s stock valued at $26,095,000 after acquiring an additional 902,000 shares during the period. Conestoga Capital Advisors LLC grew its stake in shares of OrthoPediatrics by 16.2% in the third quarter. Conestoga Capital Advisors LLC now owns 74,975 shares of the company’s stock worth $1,670,000 after acquiring an additional 10,440 shares during the period. Ellsworth Advisors LLC bought a new stake in shares of OrthoPediatrics in the third quarter worth approximately $900,000. GAMMA Investing LLC grew its stake in shares of OrthoPediatrics by 70.3% in the third quarter. GAMMA Investing LLC now owns 1,165 shares of the company’s stock worth $26,000 after acquiring an additional 481 shares during the period. Finally, Squarepoint Ops LLC raised its holdings in shares of OrthoPediatrics by 95.0% during the second quarter. Squarepoint Ops LLC now owns 195,468 shares of the company’s stock valued at $3,739,000 after purchasing an additional 95,230 shares during the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Trading Down 1.5%

NASDAQ:KIDS opened at $33.48 on Wednesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 4.55 and a quick ratio of 2.00. The firm has a market capitalization of $874.16 million, a price-to-earnings ratio of -23.41 and a beta of 0.90. OrthoPediatrics Corp. has a one year low of $14.42 and a one year high of $34.53. The business has a fifty day moving average price of $24.47 and a 200-day moving average price of $20.08.

OrthoPediatrics (NASDAQ:KIDS) last announced its earnings results on Tuesday, October 27th. The company reported ($0.23) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.02). The company had revenue of $72.66 million during the quarter, compared to the consensus estimate of $68.50 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 12.83%. Sell-side analysts forecast that OrthoPediatrics Corp. will post -1.09 EPS for the current year.

Insiders Place Their Bets

In other news, major shareholder Squadron Capital Llc sold 302,369 shares of the firm’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.01, for a total value of $6,352,772.69. Following the transaction, the insider owned 6,201,764 shares of the company’s stock, valued at $130,299,061.64. This trade represents a 4.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Jennifer Pritzker sold 302,369 shares of the firm’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $21.01, for a total value of $6,352,772.69. Following the completion of the transaction, the insider directly owned 6,201,764 shares in the company, valued at $130,299,061.64. This trade represents a 4.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 2,100,000 shares of company stock worth $46,747,931 over the last quarter. 32.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts recently weighed in on KIDS shares. Stifel Nicolaus increased their price objective on shares of OrthoPediatrics from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Wednesday, October 28th. BTIG Research raised their target price on shares of OrthoPediatrics from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday, October 28th. Needham & Company LLC reaffirmed a “buy” rating and issued a $35.00 target price on shares of OrthoPediatrics in a research report on Wednesday, October 28th. Canaccord Genuity Group boosted their target price on shares of OrthoPediatrics from $28.00 to $30.00 and gave the company a “buy” rating in a research note on Wednesday, October 28th. Finally, Piper Sandler reiterated an “overweight” rating and set a $30.00 target price (up from $25.00) on shares of OrthoPediatrics in a research note on Wednesday, October 28th. Seven investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $30.75.

OrthoPediatrics Profile

OrthoPediatrics Corp. develops and markets orthopedic implants and instruments designed specifically for children and adolescents. Its products support surgeons treating a range of pediatric conditions, including fractures, spinal deformities, limb-length differences and other orthopedic disorders. The company’s portfolio includes systems for trauma and deformity correction, scoliosis treatment, limb lengthening and external fixation, as well as specialized surgical instruments. It also provides related education and support for pediatric orthopedic surgeons and care teams.